351 Studies Now Enrolling
Menu
Search
Medical Condition
- Show all (351)
- Addiction (2)
- Allergy, Asthma, & Immunology (2)
- Autoimmune Disorders (2)
- (-) Blood Disorders (1)
- Bone & Muscle (2)
- Cancer (92)
- Child Development (1)
- COVID-19 (Coronavirus) (11)
- Diabetes (10)
- Ear, Nose and Throat (6)
- Endocrine & Metabolic Disease (2)
- Gastrointestinal and Digestive Diseases (3)
- Hair and Skin Disorders (1)
- Healthy Volunteers (46)
- Heart Disease (26)
- Infectious Disease (12)
- Liver Disease (14)
- Lung Disease (3)
- Neurological Disorders (43)
- Nutrition (1)
- Obesity (7)
- Obstetrics & Gynecology (11)
- Pediatrics (26)
- Psychiatric Disorders (8)
- Rehabilitation (1)
- Stroke (2)
- Transplant (15)
- Urology (1)
Displaying 1 - 1 of 1
Condition: Blood Disorders / Amyloidosis
Investigator: Rajshekhar Chakraborty, MD
Status: Currently Recruiting
The purpose of this study is to see how safe and effective is the study drug, ABBV-383. ABBV-383 works by binding to a specific protein called B-cell maturation antigen, which is found on the surface of cells affected by amyloidosis. By engaging T-cells, a type of white blood cell, ABBV-383 helps activate the immune response to target and remove the…
This website uses cookies as well as similar tools and technologies to understand visitors’ experiences. By continuing to use this website,
you consent to Columbia University’s usage of cookies and similar technologies, in accordance with the
Columbia University Website Cookie Notice.
I AGREE